Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trialPaul Little, Theo Verheij, Nick Francis et al.|The Lancet|2021Cited by 51
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trialSaul N. Faust, DV Dung, Richard Haynes et al.|The Lancet Child & Adolescent Health|2024Cited by 38
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challengesJeffrey Glennon, Jan K. Buitelaar, Diane Purper‐Ouakil et al.|European Child & Adolescent Psychiatry|2013Cited by 33
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L. Bosma, Maritza A. Middelkamp‐Hup, Wouter Ouwerkerk et al.|JAAD International|2022Cited by 10
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositisCharalampia Papadopoulou, Paul Brogan, Hakim‐Moulay Dehbi et al.|Lara D. Veeken|2024Cited by 7